NOTICE IS HEREBY GIVEN THAT SG Securities (HK) Limited, a company incorporated in Hong Kong whose registered office is at Level 38, Three Pacific Place, 1 Queen’s Road East, Hong Kong (the “Transferor”), has agreed to sell and transfer to Amundi Hong Kong Limited, a company incorporated in Hong Kong whose registered office is at Suite 901–908, One Pacific Place, No. 88 Queensway, Hong Kong (the “Transferee”) its business of promoting and/or distributing Lyxor products and funds in Hong Kong (the “Business”) under the name of SG Securities (HK) Limited as carried on in or from the registered office of the Transferor and certain assets and liabilities thereof in relation to the Business.
The transfer is expected to become effective on 31 December 2021 (subject to regulatory approval) or such other date as the Transferor and Transferee may otherwise agree (the “Transfer Date”). With effect from the Transfer Date, the Transferee intends to carry on the Business in succession to the Transferor at the registered office of the Transferee under the name of Amundi Hong Kong Limited and/or such other name(s) as may be used by the Transferee under which to conduct the Business.
Notice is hereby given that at the expiration of one (1) month after the date of the last publication of this notice, the liability of the Transferee (if any) for all the debts and obligations arising out of the carrying on of the Business by the Transferor up to but excluding the Transfer Date shall cease by virtue of the Transfer of Businesses (Protection of Creditors) Ordinance unless legal proceedings in respect of such debts and obligations are instituted prior to such expiration.
Dated the 26th day of November 2021.
SG Securities (HK) Limited
Level 38, Three Pacific Place, 1 Queen’s Road East, Hong Kong
Amundi Hong Kong Limited
Suite 901–908, One Pacific Place, No. 88 Queensway, Hong Kong